Skip to content
Lower risk Medical device recall · FDA · Published February 4, 2022

Cytocell TCL1 Breakapart Probe Recall: Unexpected DNA signals risk

Cytocell recalls TCL1 Breakapart Probe for possible unexpected DNA signals. Learn if you have the affected product and what to do.

🇺🇸 FDA recall #Z-0814-2022Medical deviceCytoc:ell ›
Take action

Contact the company

Recalling firmCytocell Ltd.418 Cambridge Science Park, Milton Road, Oxford Gene Technology · Cambridge, United Kingdom
✎ GovInfoNow plain-language explainer

Cytocell is recalling its TCL1 Breakapart Probe due to a risk of showing unexpected DNA signals. This could lead to inaccurate results in genetic testing. Affected users should check their product details and contact Cytocell for guidance. Read more at govinfonow.com/recall/61180-cytocell-tcl1-breakapart-probe-recall-unexpected-dna-signals-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/61180-cytocell-tcl1-breakapart-probe-recall-unexpected-dna-signals-risk · Updated August 18, 2026 · FDA enforcement record: FDA #Z-0814-2022

Cite this page

“Cytocell TCL1 Breakapart Probe Recall: Unexpected DNA signals risk.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/61180-cytocell-tcl1-breakapart-probe-recall-unexpected-dna-signals-risk. Based on FDA recall #Z-0814-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0814-2022%22&limit=1).

The FDA announced on Feb. 4, 2022, that Cytocell Ltd. voluntarily recalled one unit of its TCL1 Breakapart Probe due to a Class III hazard. The device may show unexpected locus specific signals in addition to those at 14q32.

How to tell if you have it

  • Brand: Cytocell
  • Product: TCL1 Breakapart Probe
  • Catalog Number: LPH046-A
  • Lot Code: 074612
  • Quantity: 1 unit

The hazard

The recall record states the probe may show unexpected locus specific signals in addition to those at 14q32. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Cytocell Ltd. has 12 other recalls on record since March 15, 2019. Other recent recalls of similar products include Exploro Fertility Test Recall (Nov. 22, 2025), Changchun Wancheng Bio-Electron UTI Test Strips Recall (Nov. 22, 2025), and Changchun Wancheng Male Fertility Sperm Test Cassette Recall (Nov. 22, 2025).

How to tell if you have this one

Check for catalog number LPH046-A and lot number 074612 on the product. The probe is used in fluorescence in situ hybridisation (FISH) genetic testing.

  • Brand
    Cytoc:ell
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for catalog number LPH046-A and lot number 074612 on the probe.

Where it went and when

Where it was distributed

Distributed in Minnesota.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: yesMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “MN” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Minnesota.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Feb 4, 202212. FDA classified it Class III: Mar 21, 202223. Published in FDA’s Enforcement Report: Mar 30, 202234. FDA terminated the recall: Nov 6, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0814-2022 (February 4, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0814-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA